Background: Transcription factors regulate gene expression and play important role in tumor genesis. Especially, the E2F transcription factor family controls the cell cycle and regulate many tumor suppressors. Missense variants in E2F family genes, which change the amino acid sequence, may alter the capacity for DNA binding or the protein structure, leading to a functional alteration. Material and Methods: We here searched for missense variants in E2F transcription family genes (E2F1~E2F8) and identified two (rs2075995 for E2F2 and rs3829295 for E2F7) with minor allele frequencies >0.01 in Chinese Han Beijing population from the 1000 genome project. We genotyped these two variants in 1,055 colorectal cancer (CRC) patients and 1,936 healthy controls using Taqman genotyping assays and assessed associations between SNPs and risk of CRC using logistic regression adjusted for gender and age. Results: We found rs3829295 at E2F7 to be significantly associated with risk of CRC. Compared with TT genotype carriers, CT and CT+CC genotype carriers had lower risks of CRC with ORs of 0.61 (95% CI: 0.44-0.85, P=0.003) and 0.61 (95% CI: 0.44-0.84, P=0.003), respectively. When stratified by gender and age, significant associations were observed in males (OR= 0.56, 95% CI: 0.38-0.83, P=0.004) for rs3829295, but not females (OR= 0.73, P=0.232). Conclusion: Through a systematic assessment of variants in the E2F transcription factor family, we identified a lowfrequent missense variant in E2F7 significantly associated with CRC risk, indicating that E2F7 may play an important role in development of this tumor type.
Introduction
Colorectal cancer (CRC) ranks the third most commonly cancer in males and the second in females, with an estimation of 71,830 men and 65,000 women diagnosed with colorectal cancer in 2014 (Siegel et al., 2014; Torre et al., 2015) . Although the incidence rates of CRC decreased by approximately 3% per year during the past decades in western countries (Siegel et al., 2014) , with the progressive 'westernization' of lifestyles, the incidence rates of CRC in China is sharply increasing (Chen et al., 2016) . Although some environmental factors were established to play an important role in the etiology of CRC, it is estimated that approximately 35% of CRC risk may be attributable to inherited factors (Lichtenstein et al., 2000) . Previous genome-wide association study could only explain a small fraction of the heritability. Therefore, more variants, especially functional variants with low-frequency still need to be explored. Transcription factors are proteins that controls the rate of transcription of genetic information form DNA to mRNA by binding to a specific DNA sequence. In turn, they regulate the expression of genes and paly a very important role in both cell activity and tumor genesis. A better understanding of the regulatory factors that contribute in the development of CRC could provide new insights into precision medicine of this disease. The E2F transcription factor family is a crucial group of transcription factors that involved in the cell cycle regulation and carcinogenesis (Chen et al., 2009; Polager and Ginsberg, 2009) . There are eight genes in this family (E2F1~E2F8) and three of them are activators (E2F1, E2F2 and E2F3a). Missense variants, that change the amino acid of proteins, may alter the function of transcription factors and lead to a dysregulation of downstream genes.Thus, we conjecture that missense variants in E2F family genes may associate with CRC susceptibility.
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Identification of a Low-Frequency Missense Variant in E2F
In the present study, we searched for missense variants in the E2F transcription factors family (E2F1~E2F8) and performed a case-control study to test whether these variants is associated with CRC risk.
Materials and Methods
Study subjects
This study consists of 1,055 CRC patients and 1,936 healthy controls. CRC patients were enrolled from People's Hospital of Zhengzhou University and Henan Provincial People's Hospital, Zhengzhou, China between January 1st, 2012 to November 30th, 2015. Health controls were selected from a community cancer screening program for early detection conducted in the same region during the same period as cases were collected. All participants were unrelated Han Chinese descent, and the inclusion criteria included pathologically confirmed primary CRC, without any radiotherapy or chemotherapy treatment prior to blood samples collected. The informed consent was obtained from every participant at recruitment and peripheral blood samples and demographic characteristics such as gender, age and ethnicity were collected by interviewers. This study was conducted under the approval of the Institutional Review Board of Zhengzhou University.
SNP selection and genotyping
We searched for missense variant in E2F transcription factor family genes (E2F1~E2F8) using Ensembl (http:// asia.ensembl.org/). rs2075995 at E2F2 and rs3829295 at E2F7 with MAF in Chinese Han Beijing (CHB) > 0.01 were selected for genotyping. Genotyping were performed using genomic DNA extracted from 2 ml peripheral blood sample collected from each participant at recruitment. SNPs were genotyped by Taqman SNP Genotyping Assay (Applied Biosystems). The PCR primers and probes for genotyping rs2075995 and rs3829295 were 5′-GAG GAT ATC TCT TGT TGG CCT TGT-3′/5′-GAC CTG GGA AGC AGC AAC AG-3′, 5′-FAM-CTG GAT GAG CTG GTC-MGBNFQ-3′/5′-HEX-CTG GAT GAG ATG GTC-MGBNFQ-3′ and 5′-AGC TCA GGG CTA ACA GGA TGT C-3′/5′-AAA GGC AAA GTA GGG AAT ATG AAG AC-3′, 5′-FAM-CCT TAC CTT GGG CAC GA-MGBNFQ-3′/5′-HEX-TTA CCT TGG GCA TGA C-MGBNFQ-3′. Several genotyping quality controls were implemented, including (i) the case and control samples were mixed in the plates, and persons who performed the genotyping assay were not aware of case or control status, (ii) positive and negative (no DNA) samples were included on every 384-well assay plate, and (iii) we further employed the direct sequencing of PCR products to replicate sets of 50 randomly selected, TaqMan-genotyped samples for the two SNPs and the accordance between the two methods was 100%.
Statistical analysis
Odds ratios (ORs) and 95% confidence intervals (CIs) adjusted for age and sex gender were used to assess the strength of associations between selected polymorphisms and CRC risk by using unconditional multivariate logistic regression analysis. All statistical analyses were performed using SAS software (version 9.1; SAS Institute, Cary, NC), with a significance level of 0.05. All tests were two-sided.
Results
Characteristic of Study Subjects
The distributions of selected demographic characteristics including sex gender and age of the CRC patients and healthy controls were summarized in Table  1 . The present study included 1,055 CRC patients and 1,936 gender matched healthy controls. There were 66.9% and 62.4% males in cases and controls, respectively. The average age of cases and controls were 60.5 and 64.8, respectively.
Association between Missense SNPs in E2F family Genes and CRC Risk
Missense variant in E2F transcription factor family genes (E2F1~E2F8) were searched. SNPs with global minor allele frequency (MAF)>0.001 were listed ( Table  2) . Two SNPs (rs2075995 at E2F2 and rs3829295 at E2F7) with MAF in Chinese Han Beijing (CHB) > 0.01 were selected for genotyping.
The genotype frequencies of the two selected SNPs and their associations with CRC risk were showed in 
Stratified Analysis of Missense SNPs in E2F Family Genes and CRC Risk
We performed stratified analyses by age and gender to evaluate the effects of variant genotypes on the risk of CRC (Table 4) . Among the males, rs3829295 significantly associated with CRC susceptibility with an odds ratio of 0.56 (95% CI: 0.38-0.83, P= 0.004). However, the association were not observed for females (OR= 0.73, 95% CI: 0.43-1.22, P=0.232). When stratified by age, rs3829295 were significantly associated with CRC risk in both younger (< 65 years) and older (≥ 65 years) participants with the OR being 0.59 (95% CI: 0.36-0.97, P=0.037) and 0.64 (95% CI: 0.43-0.96, P=0.031), respectively. For rs2075995, no significant associations
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Gender, n (%) important role of E2F7 in CRC carcinogenesis. The E2F7 gene is located at chromosome 12q21.2, containing 14 exons. As a member of E2F transcription factor family, E2F7 play an essential role in the regulation of cell cycle progression (Di Stefano et al., 2003) . However, in contrast to the E2F activators (eg. E2F1 and E2F2), E2F7 can block the E2F-dependent activation of a subset of E2F target genes as well as mitigate cellular proliferation of mouse embryo fibroblasts (de Bruin et al., 2003) . It was also reported that E2F7 and E2F8 works as a unique repressive arm of the E2F transcriptional network that controls the E2F1-p53 apoptotic axis (Li et al., 2008; Liu et al., 2013) . E2F7 and E2F8 expression is induced in were observed in stratified analyses.
Discussion
In this hospital-based case-control study, we explored the association between missense variants in E2F transcription factors family and CRC susceptibility in 1,055 CRC patients and 1,936 controls.We found the frequency of the TC/CC genotypes of the rs3829295 were significantly lower than that of TT genotypes, especially in males.The results from the present study suggest thatrs3829295 T>C polymorphism in E2F7 was significant associated with CRC risk, indicating an Table 4 . Association of rs3829295 and CRC Risk Stratified by Gender and Age response to DNA damage, which is partially dependent on P53 (Zalmas et al., 2008; Aksoy et al., 2012; Carvajal et al., 2012) . Accumulating evidence showed that E2F7 may act as a tumor suppressor in multiple types of cancer by blocking cell proliferation (de Bruin et al., 2003; EndoMunoz et al., 2009; Mitxelena et al., 2016; Thurlings et al., 2016) . E2F7 has two DNA binding domains and binds to the E2F DNA binding consensus site independently of DP co-factors (Logan et al., 2004) . A mutational analysis indicates that the integrity of both DNA-binding domains is required for cell cycle delay and transcriptional modulation (Logan et al., 2004) . However, the rs3829295 T>C polymorphism cause a 626th amino acid change (Met > Val), not an amino acid change in the DNA binding domain of E2F7. Although not lead to a direct alteration to the DNA binding capacity of E2F7, the variant may function through other ways, such as influencing on the formation of E2F7 homodimer (Logan et al., 2004) . Significant association between this variant and CRC risk with a relatively high effect size (OR=0.61 in dominant model) was observed in this study. The high effect size and not been identified by previous GWAS explain by its relatively low frequency in Chinese population (CHB MAF = 0.0485) and potential important function.The association was significant especially in males but not females, indicating a gender disparities for CRC. This results all indicated that further functional analysis is worthy to be performed to elucidate the relationship between rs3829295 and CRC in the future.
In summary, through a case-control study in a Chinese Han population, we find a significant association between E2F7 missense variant rs3829295 and CRC susceptibility, especially in males. This results expand our insights of CRC carcinogenesis and provide more evidence for the precision medicine of this disease.
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